Abstract:RationaleIn pulmonary arterial hypertension (PAH), endothelial cells (ECs) exhibit increased migration/proliferation leading to formation of vaso‐occlusive lesions. The mechanisms underlying this pro‐migratory/proliferative state remain unclear. Increased ROS and intracellular Ca2+ concentration ([Ca2+]i) are known to promote migration and proliferation in other vascular beds, and there is evidence for increased oxidant stress and basal [Ca2+]i in ECs from humans with PAH. Although the exact source of increased EC oxidant stress in PAH ECs is not fully known, mitochondria are a significant source of ROS in ECs, and mitochondrial dysfunction is present in human PAH ECs. However, the links between ROS production, elevated [Ca2+]i and enhanced migration and proliferation in PAH ECs are incompletely understood.We previously showed that exogenous ROS increased [Ca2+]i in lung microvascular endothelial cells (MVECs) via the transient receptor potential vanilloid‐4 (TRPV4) calcium channel. To study endogenous ROS production and the possible role of ROS‐induced Ca2+ influx in promoting MVEC migration and proliferation in PAH, we isolated MVECs from the lungs of rats subjected to normoxia (N‐MVEC) or SU5416/hypoxia (SuHx‐MVEC), a robust model of PAH, and examined ROS production, [Ca2+]i, mitochondrial morphology/function and cellular migration and proliferation.MethodsCa2+ was measured using Fura‐2AM‐loaded MLMVEC in a flow chamber perfused with Krebs buffer. Mitochondrial morphology measurements were made using validated algorithms on confocal images of mitochondria in N‐ and SuHx‐MVEC transfected with MitoRFP. ROS measurements were made using the ratiometric ROS sensor roGFP. Migration and proliferation were measured using transwell assay and BrDU incorporation, respectively.ResultsROS levels were increased in SuHx‐MVEC and attenuated following treatment with MitoQ (MQ) a mitochondrion‐specific antioxidant. In SuHx‐MVECs, mitochondrial number, network fragmentation and activation of the fission‐inducing protein dynamin‐related protein 1 were increased, while oxidative phosphorylation and mitochondrial membrane potential were both decreased. Basal [Ca2+]i, migration and proliferation were all increased in SuHx‐MVEC, but similarly attenuated following treatment with: 1) MQ; 2) a global ROS scavenger (TEMPOL); or 3) HC‐067047, a specific TRPV4 inhibitor. While total TRPV4 expression was unchanged between N‐ and SuHx‐MVEC, activation of membrane bound TRPV4 (using the specific agonist GSK1016790A ‐ GSK) produced greater [Ca2+]i influx in SuHx‐MVEC. Biotinylation of TRPV4 revealed greater membrane‐bound expression of TRPV4 in SuHx‐MVEC. Interestingly, quenching mitochondrial ROS attenuated GSK‐induced [Ca2+]i influx in SuHx‐MVEC.ConclusionThese data suggest that, in SuHx‐MVEC, mitochondrial ROS promote membrane translocation of TRPV4, leading to increased basal [Ca2+]i and enhanced migration and proliferation.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Regulation of endothelial cell mitochondrial phenotype by mechanosensitive ion channel TRPV4

A TRPV4 Channel C-terminal Folding Recognition Domain Critical for Trafficking and Function.

TNFR 2 Stimulation Promotes Mitochondrial Fusion Via Stat 3-and NF-kB – Dependent Activation of OPA 1 Expression

Distinct calcium regulation of TRPM7 mechanosensitive channels at plasma membrane microdomains visualized by FRET-based single cell imaging

TRPV4 modulation affects mitochondrial parameters in adipocytes and its inhibition upregulates lipid accumulation

Deletion of Endothelial TRPV4 Protects Heart From Pressure Overload-Induced Hypertrophy

Role of Mitochondrial Reactive Oxygen Species (ROS) and TRPV4 Activation in Microvascular Endothelial Cell Dysfunction in PAH.

Mitochondrial ROS (mtros) Production and TRPV4 Translocation/activation in Lung Microvascular Endothelial Cells

Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy

TRPV4 channels regulate tumor angiogenesis through the modulation of Rho‐dependent tumor endothelial cell mechanosensitivity

TRPV4 Channels Modulate Pathological Angiogenesis via Rho/Rho Kinase Pathway

A human mitochondrial isoform of TRPV1 regulates intracellular Ca2+ simultaneously with mitochondrial thermolysis

TRPV4 regulates matrix stiffness and TGFβ1-induced epithelial-mesenchymal transition

Modulating mitochondrial calcium channels (TRPM2/MCU/NCX) as a therapeutic strategy for neurodegenerative disorders

Activation of TRPA1 and TRPV1 in vagal nociceptive sensory neurons by inhibitors of mitochondrial function

Pharmacological Modulation of Mitochondria Ca2+Exerts Divergent Effects on Arrhythmogenic Calcium Waves in Ca2+-dependent and Metabolic Cardiac Disease

Integrated single-cell RNA-seq analysis reveals mitochondrial calcium signaling as a modulator of endothelial-to-mesenchymal transition

Importance of Non-Selective Cation Channel TRPV4 Interaction with Cytoskeleton and Their Reciprocal Regulations in Cultured Cells

Abstract 18772: Transient Receptor Potential Cation Channel 6 (TRPC6) Deficiency Preserves Cardiac Mitochondrial Respiration and Attenuates Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction

The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 Myoblasts

TRPV4 and the Regulation of Vascular Tone